CELL AND GENE THERAPY

Research and Discovery Solutions

Identify cell and gene therapy solutions for your product development programs, including unique structural and functional assay support, viral vector platforms, target identification and characterization, and labware needed for your discovery process

CELL AND GENE THERAPY DEVELOPMENT

Accelerate cell and gene therapy product development

Azenta Life Sciences provides technology innovations and proprietary protocols to bring your cell and gene therapy products to the forefront. Partner with Azenta’s experts to design and generate viral vector packaging for both in vivo and in vitro research.

Azenta_Discovery_Redefine_Image
Target - Discover

CELL THERAPY & ASSAY DEVELOPMENT 

Analyze your disease samples for mutations, and deliver validated drug targets in a variety of therapeutic areas.

Services include: RNA Sequencing, Mutation Analysis, Oligo Synthesis, Cell Line Engineering Confirmation, and Integration Site Analysis

Search - Discover

VIRAL VECTOR PLATFORMS & SEQUENCING

Deliver the right vector package for your gene therapy research and workflows.

Services include: RNA Sequencing, CRISPR Validation Services, gRNA Construct Synthesis, AAV ITR Sanger Sequencing, Whole AAV Genome Sequencing, Synthetic DNA Solutions, Viral Production Bundle (AAV Packaging, Lentivirus, Baculovirus), and Digital PCR (dPCR)

GENE THERAPY AND RARE DISEASES

Customer Testimonial: AskBio

watch_video

CELL AND GENE THERAPY DEVELOPMENT

AskBio: Leader in the gene therapy space finds AAV solutions with Azenta

 

AskBio is focused on the development of new gene therapy technologies to address debilitating genetic diseases. Their technologies and treatments make significant impacts to patient lives with Azenta’s Adeno-associated virus (AAV) vector solutions helping to overcome product development challenges.

CELL AND GENE THERAPY CHALLENGES

Clearing Roadblocks in Early-Stage Cell & Gene Therapy Development

Biotech companies are encountering common bottlenecks for discovery and scale-up. Gene therapy vectors like AAV contain features that can interfere with traditional QC methods. However, recent innovations are overcoming these challenges.

CELL AND GENE THERAPY SOLUTIONS

Support your entire workflow with proven and effective cell and gene therapy solutions

Azenta Life Sciences offers a full range of compatible solutions to support your cell and gene therapy product development. Please see below for more information on our total cell and gene therapy discovery solutions.

AAV Solutions

When precision matters, Azenta's suite of AAV solutions help target and manipulate cell types based on expression, location, and connectivity.

AAV Plasmid Synthesis
Whole AAV Genome Sequencing

Verify the integrity of packaged AAV vectors, measure AAV expression after infection, and monitor host response.

AAV-ITR Sanger-1
AAV-ITR SANGER SEQUENCING

Utilizes Sanger protocols to sequence-confirm difficult ITR regions, expediting screening and validation of lead candidates.

AAV Plasmid Synthesis
AAV PLASMID SYNTHESIS

The first of its kind, this provides researchers with synthesis and cloning of transgene expression cassettes into custom AAV vectors.

Cryogenic Lab Equipment

Rely on the highest-quality cryogenic consumables and instruments to support research and development for temperature-sensitive applications.

Cryogenic Consumables
Cryogenic Sample Tubes

Built for automation, Azenta's tri-coded and dual-coded sample tubes offer tracking, auditing, and data sharing.

Cryopod
CryoPod™ Carrier

The LN2 vapor-based CryoPod Carrier is a portable, lightweight, and portable solution capable of  storing samples at ≤ -150°C for over 3 hours.

Benchtop Heating & Cooling Solutions
Cell Freezing Containers

Unbreakable, easy and safe to open when frozen, Azenta's cell freezing containers control the rate of heat removal to provide reproducible results. 

CELL AND GENE THERAPY RESOURCES

Resources for your cell and gene therapy product development

Accelerate your workflow and deliver results with Azenta's comprehensive offering. Have questions? Azenta's team of scientists and experts can provide additional assistance.

RNA Sequencing

Download PDF >

Gene-to-Lentivirus 

Download PDF >

Gene-to-Baculovirus

Download PDF >

AAV Genome Sequencing 

Download PDF >

AAV Plasmid Synthesis 

Download PDF >

AAV Plasmid Preparation

Download PDF >

AAV-ITR Sanger Sequencing 

Download PDF >

AAV Packaging

Download PDF >

CryoPod and Filling Station 

Download PDF >

Digital PCR (dPCR) 

Download PDF >

Labware and Consumables 

Download PDF >

Webinar: Innovative Genomics and Cold Chain Solutions for Cell and Gene Therapy Development

Watch Webinar >

Webinar: A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy

Watch Webinar >

Webinar: Understanding the Challenges and Opportunities of Biological Sample Cryopreservation

Watch Webinar >

Video: AskBio AAV Solutions in Gene Therapy

Watch Video >

Tech Note: Reading Through the Inverted Terminal Repeats (ITRs) of Adeno-Associated Virus (AAV)

Download >

Tech Note: Integration Site Analysis for Long-Term Safety Monitoring of Cell and Gene Therapy Products

Download >

Adeno-Associated Virus (AAV) Services

Learn More >

Tech Note: An Efficient and High-Fidelity Approach to AAV Plasmid Preparation

Download >

Tech Note: An Efficient and High-Fidelity Approach to AAV Packaging

Download >

CELL AND GENE THERAPY COMMERCIALIZATION

Prepare your cell and gene therapy programs for scalable product development

 

 

 

Preclinical & Clinic 

VECTOR & CELL BANK CONFIRMATION | CLINICAL TRIALS

 

 

Manufacturing & Distribution 

MANUFACTURING SCALE-UP | THERAPEUTICS MANAGEMENT

 

CELL AND GENE THERAPY DISCOVERY

Subscribe for cell and gene therapy updates

Want to validate, optimize, or scale up right now? Need to know what's next? Connect with Azenta Life Sciences, leading the way in cell and gene therapy infrastructure and expertise.